The Aurealix Architecture — V2.0
A conceptual framework for adaptive bioelectronic and biopharmaceutical technologies.
The architecture integrates six complementary scientific frameworks while distinguishing conceptual principles from specific devices, algorithms and patent-protected implementations.
Integrated architecture
Observation, reasoning, validation and longitudinal adaptation.
Aurealix is organized as a technology-independent architecture for physiological observation, functional interpretation, state estimation, uncertainty-aware reasoning, transition modelling and long-term model alignment.
APR adds a longitudinal temporal perspective without replacing the established responsibilities of AFN, APIM, NSPP, BNPSS and STM. Historical evidence and validation interact across the complete architecture.
Six complementary frameworks
Distinct scientific questions. One coherent architecture.
Each Innovation Note addresses a specific architectural responsibility. No framework acts as the parent architecture of the others.
AFN
Adaptive Functional Neurocartography.
Maps individualized functional response regions and response landscapes.
APIM
Adaptive Peripheral Intent Mapping.
Interprets peripheral physiological signals as functional intent and context.
NSPP
Neurophysiological State Stabilization and Proteostasis Preservation.
Represents and anticipates neurophysiological states relevant to stabilization and proteostasis preservation.
BNPSS
Bioelectronic Neurocartography for Proteostasis State Stabilization.
Supports uncertainty-aware physiological reasoning under incomplete and variable information.
STM
Sensorimotor Transition Mapping.
Models transitions between functional and neurophysiological states.
APR
Adaptive Physiological Reorganization.
Addresses long-term physiological reorganization, model validity, drift and evidence-bounded recalibration.
Architectural position
Conceptual architecture is not yet a finished technology.
The Aurealix Architecture defines scientific questions, interfaces and validation directions. It does not claim that a complete software platform, therapeutic system or clinically validated implementation already exists.
Specific sensing modalities, computational methods and therapeutic technologies remain implementation-dependent and require separate technical and scientific validation.
Version 2.0